AstraZeneca has received a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) for a protocol being amended to widen the ongoing global clinical trial
Merck (known as MSD outside of the US and Canada) presented positive Phase 3 trial results for Capvaxive for kids at the 6th ESCMID Conference on Vaccines in Lisbon, Portugal. The STRIDE-13 study assessed the vaccine in children and adolescents...
The World Health Organization (WHO) has announced the establishment of a Guideline Development Group (GDG) to develop the first evidence-based recommendations on multiplex testing for HIV, viral hepatitis, and sexually transmitted infections (STIs)..
Hyderabad-based Dr Reddy's Laboratories said on Tuesday that it has finalized a definitive transaction the Stugeron brand from Johnson & Johnson across the EMEA countries, describing India and Vietnam as important growth markets for Stugeron...
Pfizer Inc. and BioNTech SE announced promising topline findings from a phase 3 study of their LP.8.1-adapted Comirnaty Covid-19 vaccine (2025-2026 Formula) that targets the SARS-CoV-2 evolution. The study involved adults aged 65 and older and...
Mankind Pharma, India's fourth largest pharma company, has received approval from CDSCO to conduct a phase 1 clinical trial for its new JAK-1 inhibitor, MKP11093. The orally available drug molecule, which has been developed at Mankind Research...
Glenmark Pharmaceuticals has also begun a global Phase 3 clinical trial with Envafolimab, a new medication to treat patients with third stage non-small cell lung cancer (NSCLC). The shift highlights the increasing role of India in late-stage drug dev
Edwards Lifesciences has launched its new-gen transcatheter heart valve platform in India, marking a significant advance in the treatment of severe aortic stenosis. The system is intended for patients that are not suitable candidates for open-hear...
The Maharashtra Food and Drug Administration (FDA) has made substantial improvements to its testing facilities to address the continued high demand for drug regulation and quality testing. The FDA’s laboratories in Mumbai and Aurangabad have...
The plan by healthcare giant Manipal Hospitals to buy Pune-based Sahyadri Hospitals from international investor Ontario Teachers' Pension Plan Board in a deal valued at around Rs. 6,400 crore has been approved by the Competition Commission of India